Materias dentro de su búsqueda.
Mostrando 1,541 - 1,560 Resultados de 5,148 Para Buscar '"Ph. D."', tiempo de consulta: 0.37s Limitar resultados
  1. 1541
    “…The nonspecific enrichment of target-unrelated peptides during biopanning remains a major drawback for phage display technology. The commercial Ph.D.(TM)-7 phage display library is used extensively for peptide discovery. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A White Plaque, Associated with Genomic Deletion, Derived from M13KE-Based Peptide Library Is Enriched in a Target-Unrelated Manner during Phage Display Biopanning Due to Propagation Advantage
  2. 1542
    Publicado 2022
    “…We look forward to another outstanding season of submissions for OSET 2023. Phil Page PhD, PT, ATCChuck Thigpen PhD, PT, ATC OSET Research Committee Co-Chairs…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2022 IJSPT Orthopedic Summit Research Abstracts
  3. 1543
    “…Emergency care research capacity in Africa may be expanded through the development of doctoral programmes that aim to upskill the PhD student into an independent scholar, through dedicated support and structured learning. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Emergency medicine doctoral education in Africa: a scoping review of the published literature
  4. 1544
    “…DISCLOSURES: Meredith Hackel, PhD, Pfizer Inc.: Honoraria|Venatorx: Paid fees for conducting the study and abstract preparation Gregory Stone, PhD, Pfizer: Stocks/Bonds Daniel F. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2127. In vitro Activities of Ceftaroline and Comparator Agents against Bacterial Pathogens Frequently Causing Community-Acquired Respiratory Tract Infections in Patients from a Global Population: ATLAS Surveillance Program 2018-2021
  5. 1545
    “…Gotur, MD, FCCP, FCCM, GSK: Advisor/Consultant|GSK: Speaker at ATS|Moderna: Advisor/Consultant Vadim Markovtsov, PhD, Rigel Pharmaceuticals, Inc.: Employee|Rigel Pharmaceuticals, Inc.: Stocks/Bonds Lucy Yan, MD, PhD, Rigel Pharmaceuticals, Inc.: Employee|Rigel Pharmaceuticals, Inc.: Stocks/Bonds Wolfgang Dummer, MD, PhD, Rigel Pharmaceuticals, Inc.: Stocks/Bonds. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    88. Fostamatinib for the Treatment of Hospitalized Patients With COVID-19 Who Required Oxygen Supplementation: Results of a Phase 3 Trial
  6. 1546
    “….: Stocks/Bonds Katherine E. Mues, PhD, Aetion, Inc.: Employee Shaina Desai, MPH, Aetion, Inc.: Employee Brent Arakaki, BS, Aetion, Inc.: Employee Priyadarshani Dharia, PhD, MD, MPH, Moderna, Inc.: Salary|Moderna, Inc.: Stocks/Bonds Parinaz Ghaswalla, PhD, Moderna, Inc: Employee|Moderna, Inc: Stocks/Bonds Yoonyoung Park, ScD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2375. Contemporary Patterns and Predictors of Influenza and COVID-19 Vaccination Among US Adults During the COVID-19 Pandemic
  7. 1547
    “…Nimmi Kothari, PhD, Allecra: Allecra (study funding)|Innoviva Specialty Therapeutics, Inc.: Honoraria|Roche: Honoraria|Roche: This project has been funded by BARDA (HHSO100201600038C). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2131. Activity of the Novel Antibiotic Zosurabalpin (RG6006) against Clinical Acinetobacter Isolates from China
  8. 1548
    “…DISCLOSURES: Alita Miller, PhD, Entasis Therapeutics: employee|Entasis Therapeutics: Stocks/Bonds Sarah McLeod, PhD, Innoviva Specialty Therapeutics: Employee|Innoviva Specialty Therapeutics: Employee|Innoviva Specialty Therapeutics: Stocks/Bonds|Innoviva Specialty Therapeutics: Stocks/Bonds Adam B. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    85. Efficacy of Sulbactam-Durlobactam (SUL-DUR) Compared to Colistin (COL) against Acinetobacter baumannii-calcoaceticus Complex (ABC) Monomicrobial and Polymicrobial Infections in a Phase 3 Trial
  9. 1549
    “…The Translational Research Design and Interprofessional Skills Development Course (shortened, Interprofessional Research Design) brings together students from different disciplines (science & medicine) and education tracks (PhD, MD, MD/PhD training) in a seven-week course to learn interprofessional collaborative skills and leadership styles that support success in translational research environments, while undertaking a research grant writing project. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    3302 Student Leadership Training effects on team dynamics and collaborative work in high-pressure, interprofessional team environments
  10. 1550
    “…DISCLOSURES: Dana Walsh, PhD, Rebiotix Inc. (Employee) Carlos Gonzalez, MS, BioRankings, LLC (Employee) Bill Shannon, PhD MBA, BioRankings, LLC (Employee) Ken Blount, PhD, Rebiotix Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    30. Antimicrobial Resistance Genes Are Reduced Following Administration of Investigational Microbiota-based Therapeutic RBX7455 to Individuals with Recurrent clostrioides Difficile Infection
  11. 1551
    “…(Employee, Shareholder) Alan Ashbaugh, PhD, SCYNEXIS, Inc. (Grant/Research Support) Melanie Cushion, PhD, SCYNEXIS, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1251. Prevention of Pneumocystis Pneumonia by Ibrexafungerp in a Murine Prophylaxis Model
  12. 1552
    “…DISCLOSURES: Rohita Sinha, PhD, Viracor-Eurofins (Employee) Steve Kleiboeker, DVM, PhD, Viracor-Eurofins (Employee) Michelle Altrich, PhD, Viracor-Eurofins (Employee) Ellis Bixler, MS, Viracor-Eurofins (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1210. K-mer Profiling Powered by Reference-assisted Assembly of NGS Data: A Highly Sensitive Protocol to Infer the Plasma Microbiome Using Cell-free DNA Sequence Data
  13. 1553
    “…(Speaker’s Bureau) Manjiri D. Pawaskar, PhD, Merck & Co., Inc (Employee, Shareholder) Phani Veerkani, MD, DrPH, Merck (Research Grant or Support) Salome Samant, MBBS, MPH, Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Carolyn Harley, PhD, Merck (Consultant) Joanna MacEwan, PhD, PRECISIONheor (Employee) Taylor T. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1387. Current practices in the diagnosis and treatment of varicella infections in the United States
  14. 1554
    “…DISCLOSURES: Thomas W. Burke, PhD, Predigen, Inc (Consultant) Geoffrey S. Ginsburg, MD PhD, Predigen, Inc (Shareholder, Other Financial or Material Support) Christopher W. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1226. Performance of a Host Response Test for Bacterial/Viral Discrimination in Immunocompromised Patients
  15. 1555
    “…Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Consultant)Shionogi & Co., Ltd. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1587. Activity of Ceftolozane/Tazobactam against Gram-Negative Isolates from Lower Respiratory Tract Infections – SMART United States 2018
  16. 1556
    “…Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Consultant)Shionogi & Co., Ltd. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1584. In Vitro Activity of Imipenem/Relebactam against Gram-Negative Pathogens from Patients with Bloodstream Infections in the United States and Canada – SMART 2018
  17. 1557
    “…Obi, PhD, Merck & Co. (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    757. Evaluating Use of the New ICD-10 Codes for Clostridioides difficile Infection in the Premier U.S. Hospital Discharge Database
  18. 1558
    “…DISCLOSURES: Elizabeth M. La, PhD, The GSK group of companies (Employee, Shareholder) Desmond Curran, PhD, The GSK group of companies (Employee, Shareholder) Ahmed Salem, MSc, The GSK group of companies (Employee) David Singer, PharmD, MS, The GSK group of companies (Employee) Nicolas Lecrenier, Ing, PhD, The GSK group of companies (Employee, Shareholder) Sara Poston, PharmD, The GSK group of companies (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    12. Modeled Impact of the COVID-19 Pandemic and Associated Reduced Adult Vaccinations on Herpes Zoster in the United States
  19. 1559
    “…Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Independent Contractor)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    203. Activity of Cefepime in Combination with Taniborbactam (formerly VNRX-5133) Against Pseudomonas aeruginosa from a Global 2018-2020 Surveillance Collection
  20. 1560
    “…DISCLOSURES: Desmond Curran, PhD, The GSK group of companies (Employee, Shareholder) Ahmed Salem, MSc, The GSK group of companies (Employee) Stéphane Lorenc, NA, GSK group of companies (Consultant) Brandon Patterson, PharmD, PhD, GSK group of companies (Shareholder) Justin Carrico, BS, GSK group of companies (Consultant)RTI Health Solutions (Employee) Katherine A. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
Herramientas de búsqueda: RSS